These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 11150997)
21. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival. Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714 [TBL] [Abstract][Full Text] [Related]
22. A partial conditioning approach to achieve mixed chimerism in the rat: depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment. Neipp M; Gammie JS; Exner BG; Li S; Chambers WH; Pham SM; Ildstad ST Transplantation; 1999 Aug; 68(3):369-78. PubMed ID: 10459540 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers. Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943 [TBL] [Abstract][Full Text] [Related]
24. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning. Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556 [TBL] [Abstract][Full Text] [Related]
25. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance. Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527 [TBL] [Abstract][Full Text] [Related]
26. Composite tissue allotransplantation in chimeric hosts part II. A clinically relevant protocol to induce tolerance in a rat model. Prabhune KA; Gorantla VS; Perez-Abadia G; Francois CG; Vossen M; Laurentin-Perez LA; Breidenbach WC; Wang GG; Anderson GL; Pidwell DJ; Barker JH; Maldonado C Transplantation; 2003 Dec; 76(11):1548-55. PubMed ID: 14702522 [TBL] [Abstract][Full Text] [Related]
27. Chimerism and tolerance: from freemartin cattle and neonatal mice to humans. Jankowski RA; Ildstad ST Hum Immunol; 1997 Feb; 52(2):155-61. PubMed ID: 9077564 [TBL] [Abstract][Full Text] [Related]
28. Reflections on the unique tolerogenicity of bone marrow, the enigma of chimerism and clinical tolerance. Monaco AP Clin Transpl; 2013; ():157-66. PubMed ID: 25095504 [TBL] [Abstract][Full Text] [Related]
29. Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts. Slavin S; Reitz B; Bieber CP; Kaplan HS; Strober S J Exp Med; 1978 Mar; 147(3):700-7. PubMed ID: 147301 [TBL] [Abstract][Full Text] [Related]
38. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. Tomita Y; Sachs DH; Khan A; Sykes M Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363 [TBL] [Abstract][Full Text] [Related]
39. Mixed chimerism through donor bone marrow transplantation: a tolerogenic cell therapy for application in organ transplantation. Pilat N; Hock K; Wekerle T Curr Opin Organ Transplant; 2012 Feb; 17(1):63-70. PubMed ID: 22186093 [TBL] [Abstract][Full Text] [Related]
40. Chimerism in hand transplantation. Szajerka T; Klimczak A; Jablecki J Ann Transplant; 2011; 16(1):83-9. PubMed ID: 21436781 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]